Amgen Inc (AMG.HA)
Hanover - Hanover Delayed price. Currency in EUR
Add to watchlist
At close: 08:00AM CEST
| Previous close | 284.15 |
| Open | 287.85 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 287.85 - 287.85 |
| 52-week range | 199.00 - 298.00 |
| Volume | |
| Avg. volume | 4 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksAmgen (AMGN) Gains As Market Dips: What You Should Know
Amgen (AMGN) closed the most recent trading day at $309.89, moving +1.27% from the previous trading session.
ZacksHere is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
ZacksAmgen's (AMGN) Blincyto Gets FDA Nod for Consolidation Treatment
Amgen's (AMGN) Blincyto is now approved for the treatment of adult and pediatric patients one month and older with Philadelphia chromosome-negative B-ALL in the consolidation phase, regardless of MRD status.
© 2024 Yahoo. All rights reserved.